Open this publication in new window or tab >>Department of Education, Toyo University, Tokyo (JPN).
Department of Cardiology, Academic Medical Center, Amsterdam (NLD); Department of Cardiology, Jeroen Bosch Hospital, ‘s-Hertogenbosch (NLD).
Department of Pediatrics, National Taiwan University Hospital, Taipei (TWN).
Center for Biobehavioral Health, Nationwide Children’s Hospital, Columbus, Ohio (USA).
Adult Congenital Heart Center, Montreal Heart Institute, Université de Montréal, Montreal (CAN).
IU Health Adult Congenital Heart Disease Program, IU School of Medicine, Indianapolis, Indiana (USA).
Pediatric Cardiology, Frontier Lifeline Hospital (Dr K. M. Cherian Heart Foundation), Chennai (IND).
Division of Cardiology, Hospital de Niños, Córdoba (ARG).
Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo (NOR).
Adult Congenital Heart Unit, Sahlgrenska University Hospital/Östra, Gothenburg (SWE); Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, Gothenburg (SWE).
University West, Department of Health Sciences, Section for nursing - graduate level.
Department of Surgery and Perioperative Sciences, Umeå University, Umeå (SWE).
Division of Cardiology, Stollery Children’s Hospital, University of Alberta, Edmonton, Alberta (CAN).
Department of Paediatrics and School of Clinical Sciences, Monash University, Melbourne, Victoria (AUS).
Department of Cardiology, Mater Dei Hospital, Birkirkara Bypass (MLT).
Adult Congenital Heart Disease Center, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio (USA).
Department of Cardiac Rehabilitation, Médipôle Hôpital Mutualiste, Lyon-Villeurbanne (FRA).
Adult Congenital Heart Program at Stanford, Lucile Packard Children’s Hospital and Stanford Health Care, Palo Alto, California (USA).
Clinical Psychology Service, IRCCS Policlinico San Donato, San Donato Milanese, Milan (ITA): Department of Biomedical Sciences for Health, University of Milan, Milan (ITA).
Adult Congenital Heart Disease Center University of Nebraska Medical Center/ Children’s Hospital and Medical Center, Omaha, Nebraska (USA).
Toronto Adult Congenital Heart Disease Program, Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario (CAN); University of Toronto, Toronto, Ontario,(CAN).
KU Leuven Department of Public Health and Primary Care, KU Leuven–University of Leuven, Leuven (BEL); Research Foundation Flanders (FWO), Brussels (BEL).
KU Leuven Department of Public Health and Primary Care, KU Leuven–University of Leuven, Leuven (BEL); Centre for Person-Centered Care (GPCC), University of Gothenburg, Gothenburg (SWE); Institute of Health and Care Sciences, University of Gothenburg (SWE); Department of Paediatrics and Child Health, University of Cape Town, Cape Town (ZAF).
Show others...
2024 (English)In: Journal of the American College of Cardiology, ISSN 0735-1097, E-ISSN 1558-3597, Vol. 83, no 3, p. 430-441Article in journal (Refereed) Published
Abstract [en]
Background: A comprehensive understanding of adult congenital heart disease outcomes must include psychological functioning. Our multisite study offered the opportunity to explore depression and anxiety symptoms within a global sample.
Objectives: In this substudy of the APPROACH-IS (Assessment of Patterns of Patient-Reported Outcomes in Adults With Congenital Heart Disease–International Study), the authors we investigated the prevalence of elevated depression and anxiety symptoms, explored associated sociodemographic and medical factors, and examined how quality of life (QOL) and health status (HS) differ according to the degree of psychological symptoms.
Methods: Participants completed the Hospital Anxiety and Depression Scale, which includes subscales for symptoms of anxiety (HADS-A) and depression (HADS-D). Subscale scores of 8 or higher indicate clinically elevated symptoms and can be further categorized as mild, moderate, or severe. Participants also completed analogue scales on a scale of 0 to 100 for QOL and HS. Analysis of variance was performed to investigate whether QOL and HS differed by symptom category.
Results: Of 3,815 participants from 15 countries (age 34.8 ± 12.9 years; 52.7% female), 1,148 (30.1%) had elevated symptoms in one or both subscales: elevated HADS-A only (18.3%), elevated HADS-D only (2.9%), or elevations on both subscales (8.9%). Percentages varied among countries. Both QOL and HS decreased in accordance with increasing HADS-A and HADS-D symptom categories (P < 0.001).
Conclusions: In this global sample of adults with congenital heart disease, almost one-third reported elevated symptoms of depression and/or anxiety, which in turn were associated with lower QOL and HS. We strongly advocate for the implementation of strategies to recognize and manage psychological distress in clinical settings. (Patient-Reported Outcomes in Adults With Congenital Heart Disease [APPROACH-IS]; NCT02150603)
Place, publisher, year, edition, pages
Elsevier, 2024
Keywords
adult; age distribution; anxiety disorder; Article; clinical feature; congenital heart disease; controlled study; demography; depression; disease classification; distress syndrome; female; health status; Hospital Anxiety and Depression Scale; human; major clinical study; male; New York Heart Association class; patient-reported outcome; prevalence; quality of life assessment; sex difference; social status; symptomatology
National Category
Nursing Cardiology and Cardiovascular Disease Psychology
Research subject
NURSING AND PUBLIC HEALTH SCIENCE, Nursing science
Identifiers
urn:nbn:se:hv:diva-21218 (URN)10.1016/j.jacc.2023.10.043 (DOI)001166976200001 ()38233017 (PubMedID)2-s2.0-85181800376 (Scopus ID)
Note
This work was supported by the Research Fund–KU Leuven (Leuven, Belgium) through grant OT/11/033, by the Swedish Heart-Lung Foundation (Sweden) through grant number 20130607, by the University of Gothenburg Centre for Person-Centered Care (Gothenburg, Sweden), by the Cardiac Children’s Foundation (Taiwan) through grant CCF2013_02, by the Research Foundation Flanders through grant 1159522N, and by the Ricerca Corrente funding from the Italian Ministry of Health to IRCCS Policlinico San Donato.
2024-03-042024-03-042025-09-30Bibliographically approved